TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 3923855

Group type: EXPERIMENTAL
Intervention: Disodium cromoglycate (DSCG) 20 mg inhaled four times a day for 2 months
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Ketotifen 1 mg orally twice a day for 2 months
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Clemastine 1 mg orally twice a day for 1 week
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo (lactose) capsule twice a day for 2 months
Number of subjects: 56
Study: 31469914

Group type: COMPARATOR
Intervention: Micro-needling (MN) alone in Group-A (9 patients)
Number of subjects: 41

Group type: COMPARATOR
Intervention: 5-aminolevulinic acid photodynamic therapy (ALA-PDT) in Group-B (15 patients)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Combination of micro-needling (MN) and 5-aminolevulinic acid photodynamic therapy (ALA-PDT) in Group-C (17 patients)
Number of subjects: 41
Study: 29138293

Group type: EXPERIMENTAL
Intervention: Clinical pathway implementation for suspected ACS including structured risk stratification, specified time points for ECG and troponin testing within 3 hours of arrival.
Number of subjects: 31332

Group type: EXPERIMENTAL
Intervention: Clinical pathway implementation for suspected ACS
Number of subjects: 31332
Study: 25794468

Group type: EXPERIMENTAL
Intervention: Monthly bisphosphonate (minodronate)
Number of subjects: 147

Group type: COMPARATOR
Intervention: Weekly bisphosphonate (alendronate or risedronate)
Number of subjects: 147
Study: 23865463

Group type: EXPERIMENTAL
Intervention: Clinical supervision sessions facilitated by psychiatrists experienced in psycho-oncology.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Randomized control trial designed to reduce anxiety and depression of distressed adults with cancer.
Number of subjects: 0
Study: 23096041

Group type: EXPERIMENTAL
Intervention: Adaptol, 25-35 mg/kg for 1-3 months
Number of subjects: 0
Study: 20030661

Group type: EXPERIMENTAL
Intervention: Experimental hookworm infection (ten Necator americanus larvae)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo (histamine solution)
Number of subjects: 32
Study: 18534242

Group type: EXPERIMENTAL
Intervention: DTaP and hepatitis B vaccines
Number of subjects: 50

Group type: COMPARATOR
Intervention: Hepatitis B alone
Number of subjects: 50
Study: 15933556

Group type: EXPERIMENTAL
Intervention: Pamphlet and videotape promoting judicious use of antibiotics
Number of subjects: 499

Group type: COMPARATOR
Intervention: Brochures about injury prevention (Control)
Number of subjects: 499
Study: 12819508

Group type: EXPERIMENTAL
Intervention: Laryngo-fiberscope passed through the PEG feeding tube
Number of subjects: 12
Study: 10228375

Group type: EXPERIMENTAL
Intervention: EMLA cream (1.5 g applied to three sites: back of the hand, antecubital fossa, side of the neck)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo cream (applied to contralateral sites)
Number of subjects: 38
Study: 7699214

Group type: EXPERIMENTAL
Intervention: Loperamide (LOP, 16 mg orally)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Dexamethasone (DXM, 1 mg orally overnight)
Number of subjects: 65
Study: 2740833

Group type: EXPERIMENTAL
Intervention: Folic acid supplementation (5 mg Folacin) for 1 year
Number of subjects: 31
Study: 4417678

Group type: EXPERIMENTAL
Intervention: Psychiatric patients who died
Number of subjects: 260
Study: 30851062

Group type: EXPERIMENTAL
Intervention: evolocumab 140 mg every 2 weeks (Q2W)
Number of subjects: 453

Group type: EXPERIMENTAL
Intervention: evolocumab 420 mg monthly (QM)
Number of subjects: 453

Group type: EXPERIMENTAL
Intervention: evolocumab
Number of subjects: 453

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 453
Study: 27081164

Group type: EXPERIMENTAL
Intervention: Traditional Greek dance rehabilitation programme (Group A)
Number of subjects: 40
Study: 24782115

Group type: EXPERIMENTAL
Intervention: Anakinra (interleukin-1 receptor antagonist)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 22085870

Group type: EXPERIMENTAL
Intervention: Nutrition education (twice weekly for 2 months)
Number of subjects: 184

Group type: COMPARATOR
Intervention: Control group (no nutrition education)
Number of subjects: 184
Study: 19957031

Group type: EXPERIMENTAL
Intervention: lamivudine
Number of subjects: 80

Group type: COMPARATOR
Intervention: control
Number of subjects: 80
Study: 18164665

Group type: EXPERIMENTAL
Intervention: Intraoperative ECoG findings including focal spiking, focal slowing in theta or delta range, and ictaform ECoG patterns.
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Resected area including anterior mesial regions where interictal spikes, ictaform activity, and slowing were localized.
Number of subjects: 40
Study: 15999135

Group type: EXPERIMENTAL
Intervention: FDT C-20-1 Screening Program
Number of subjects: 100

Group type: COMPARATOR
Intervention: Humphrey Field Analyzer (HFA) SITA Fast algorithm and Program 24-2
Number of subjects: 100
Study: 12957441

Group type: EXPERIMENTAL
Intervention: Candesartan 16 mg daily for two months
Number of subjects: 45
Study: 10888955

Group type: EXPERIMENTAL
Intervention: Unilateral pedicle screw fixation
Number of subjects: 87

Group type: COMPARATOR
Intervention: Bilateral pedicle screw fixation
Number of subjects: 87
Study: 9035511

Group type: EXPERIMENTAL
Intervention: Nucleus CMP forte (dysodic cytidinmonophosphate 5 mg, trisodic uridintriphosphate 3 mg, hydroxicobalamin 2 mg) tid for six months
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Nucleus CMP forte
Number of subjects: 46
Study: 1348775

Group type: EXPERIMENTAL
Intervention: Selective decontamination of the digestive tract (SDD)
Number of subjects: 331

Group type: COMPARATOR
Intervention: Control group (no SDD)
Number of subjects: 331
Study: 3866536

Group type: EXPERIMENTAL
Intervention: 400 mg slow-release pentoxifylline tablets ('Trental 400') twice a day for one week, followed by three times daily for seven weeks
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo tablets
Number of subjects: 38
Study: 30867201

Group type: EXPERIMENTAL
Intervention: Ceramide-dominant emollient applied two times per day from birth to 6 months
Number of subjects: 760

Group type: EXPERIMENTAL
Intervention: Ceramide-dominant emollient
Number of subjects: 760
Study: 29193350

Group type: EXPERIMENTAL
Intervention: Curcumin nanomicelle 80 mg daily for 10 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Curcumin nanomicelle
Number of subjects: 60
Study: 27508851

Group type: COMPARATOR
Intervention: Renal Denervation (RDN)
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Pharmacotherapy with spironolactone (25 mg daily)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Complete RDN
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Spironolactone addition
Number of subjects: 106
Study: 24906700

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemoradiotherapy (CRT) prior to surgery
Number of subjects: 410

Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 410

Group type: EXPERIMENTAL
Intervention: Neoadjuvant CRT
Number of subjects: 410
Study: 22364962

Group type: EXPERIMENTAL
Intervention: Group art therapy
Number of subjects: 417

Group type: COMPARATOR
Intervention: Activity group
Number of subjects: 417

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 417
Study: 20677537

Group type: EXPERIMENTAL
Intervention: Morning/morning regimen (5% BPO wash + Tretinoin gel microsphere 0.04% pump)
Number of subjects: 247

Group type: COMPARATOR
Intervention: Morning/evening regimen (BPO in the morning/Tretinoin in the evening)
Number of subjects: 247

Group type: EXPERIMENTAL
Intervention: Both regimens
Number of subjects: 247
Study: 18271278

Group type: EXPERIMENTAL
Intervention: Zinc bis-glycinate (15 mg single dose)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Zinc gluconate (15 mg single dose)
Number of subjects: 12
Study: 15673390

Group type: EXPERIMENTAL
Intervention: Inappropriate sinus tachycardia (IST) patients at rest
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Inappropriate sinus tachycardia (IST) patients during orthostatic stress
Number of subjects: 8

Group type: COMPARATOR
Intervention: Healthy volunteers (Control group) at rest
Number of subjects: 8
Study: 11895280

Group type: EXPERIMENTAL
Intervention: Combined periodontal regenerative technique (CPRT) using anorganic bovine bone and a collagen membrane
Number of subjects: 34

Group type: COMPARATOR
Intervention: GTR with a collagen membrane alone
Number of subjects: 34
Study: 10549839

Group type: EXPERIMENTAL
Intervention: Moderate physical training programme for 6 months
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sedentary lifestyle (Control)
Number of subjects: 20
Study: 8524727

Group type: EXPERIMENTAL
Intervention: Dietary and behavioral intervention
Number of subjects: 535
Study: 1837120

Group type: EXPERIMENTAL
Intervention: LO‐Tact‐1 (10 mg i.v. per day) with cyclosporin (8 mg/kg/day), low‐dose steroids (1/2 mg/kg/day), and azathioprine (1 mg/kg/day starting at day 45)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Cyclosporin, high‐dose steroids (2 mg/day at day 1), and a 14‐day course of polyclonal horse antilymphocyte globulins (ALG)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: LO‐Tact‐1 treatment
Number of subjects: 15

Group type: COMPARATOR
Intervention: Cyclosporin, high‐dose steroids, and ALG
Number of subjects: 15
Study: 7073460

Group type: EXPERIMENTAL
Intervention: Isometric handgrip contractions at 15% of maximal voluntary contractions (% MVC)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Isometric handgrip contractions at 25% of maximal voluntary contractions (% MVC)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Isometric handgrip contractions at 35% of maximal voluntary contractions (% MVC)
Number of subjects: 7
Study: 31287438

Group type: EXPERIMENTAL
Intervention: Large fascia graft (Group 1)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Small fascia graft (Group 2)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Cholesteatoma pathology
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Granulation tissue pathology
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Coexisting granulation with cholesteatoma pathology
Number of subjects: 32
Study: 30033904

Group type: EXPERIMENTAL
Intervention: Metronome assistance during CPR pre-arrival instructions
Number of subjects: 148

Group type: COMPARATOR
Intervention: Standard pre-arrival instructions without metronome assistance
Number of subjects: 148
Study: 27737408

Group type: EXPERIMENTAL
Intervention: Hypothermia group
Number of subjects: 160

Group type: COMPARATOR
Intervention: Northermia group
Number of subjects: 160
Study: 25301455

Group type: EXPERIMENTAL
Intervention: Amiodarone + Warfarin
Number of subjects: 2051

Group type: EXPERIMENTAL
Intervention: Amiodarone + Apixaban
Number of subjects: 2051

Group type: COMPARATOR
Intervention: No Amiodarone + Warfarin
Number of subjects: 2051

Group type: COMPARATOR
Intervention: No Amiodarone + Apixaban
Number of subjects: 2051
Study: 22708952

Group type: EXPERIMENTAL
Intervention: Statin therapy for 8 months
Number of subjects: 164
Study: 20165861

Group type: EXPERIMENTAL
Intervention: Intraoperative and postoperative autotransfusion (Group 1, n:92)
Number of subjects: 248

Group type: EXPERIMENTAL
Intervention: Postoperative autotransfusion (Group 2, n:71)
Number of subjects: 248

Group type: COMPARATOR
Intervention: Allogeneic blood transfusion only (Control Group 0, n:85)
Number of subjects: 248
Study: 17540994

Group type: EXPERIMENTAL
Intervention: Papaverine injected into the endothoracic tissue around the internal thoracic artery before dissection
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Papaverine injected into the periarterial tissues of the internal thoracic artery pedicle
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Intraluminal papaverine applied retrogradely into the internal thoracic artery
Number of subjects: 75
Study: 16269591

Group type: EXPERIMENTAL
Intervention: OSEM with depth-dependant resolution recovery and temporal Fourier filtering
Number of subjects: 40

Group type: COMPARATOR
Intervention: Filtered backprojection (FBP)
Number of subjects: 40
Study: 12010933

Group type: EXPERIMENTAL
Intervention: Left ventricular pacing
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Biventricular pacing
Number of subjects: 13

Group type: COMPARATOR
Intervention: Baseline (right ventricular pacing)
Number of subjects: 13
Study: 10541316

Group type: EXPERIMENTAL
Intervention: Recombinant Epo (rEpo) treatment
Number of subjects: 122

Group type: COMPARATOR
Intervention: Asphyxia
Number of subjects: 122

Group type: COMPARATOR
Intervention: Intraventricular hemorrhage (IVH)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Meningitis
Number of subjects: 122

Group type: COMPARATOR
Intervention: Controls
Number of subjects: 122
Study: 7477086

Group type: EXPERIMENTAL
Intervention: Saccharomyces boulardii (SB) 750 mg daily (250 mg t.i.d.) for 21 days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Saccharomyces boulardii (SB)
Number of subjects: 0
Study: 2182329

Group type: EXPERIMENTAL
Intervention: Q fever vaccine
Number of subjects: 200

Group type: COMPARATOR
Intervention: Influenza vaccine
Number of subjects: 200
Study: 82030

Group type: EXPERIMENTAL
Intervention: Continuous levamisole treatment
Number of subjects: 363

Group type: EXPERIMENTAL
Intervention: Intermittent levamisole treatment
Number of subjects: 363

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 363

Group type: EXPERIMENTAL
Intervention: Levamisole (both regimens)
Number of subjects: 363
Study: 31160080

Group type: EXPERIMENTAL
Intervention: Polytetrafluoroethylene strips as an adjunct to epinephrine‐impregnated gauze (test group, n = 15)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Aluminum chloride (control, n = 15)
Number of subjects: 30
Study: 28452620

Group type: EXPERIMENTAL
Intervention: Intensive periodontal therapy for 4 weeks
Number of subjects: 95

Group type: COMPARATOR
Intervention: Control treatment (CT)
Number of subjects: 95
Study: 25559202

Group type: EXPERIMENTAL
Intervention: Systematic risk selection with the Rotterdam Reproductive Risk Reduction (R4U) score card and referral to care pathways
Number of subjects: 3500

Group type: COMPARATOR
Intervention: Control group (standard antenatal care)
Number of subjects: 3500
Study: 23594451

Group type: EXPERIMENTAL
Intervention: Yoga intervention (3 sessions per week, 60 minutes each for 6 weeks)
Number of subjects: 135

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 135
Study: 22085402

Group type: EXPERIMENTAL
Intervention: 0.1 mol/L hydrochloric acid infusion
Number of subjects: 55

Group type: COMPARATOR
Intervention: Water infusion
Number of subjects: 55
Study: 19308439

Group type: EXPERIMENTAL
Intervention: Radon baths (80 Bq/l) for 15 days
Number of subjects: 27

Group type: COMPARATOR
Intervention: Thermal water with negligible radon content (6 Bq/l) for 15 days
Number of subjects: 27
Study: 17308218

Group type: EXPERIMENTAL
Intervention: Elemental diet
Number of subjects: 30

Group type: COMPARATOR
Intervention: Oral prednisolone 15 mg/day
Number of subjects: 30
Study: 15347564

Group type: EXPERIMENTAL
Intervention: Automatic oxygen control
Number of subjects: 12

Group type: COMPARATOR
Intervention: Routine manual oxygen control
Number of subjects: 12

Group type: COMPARATOR
Intervention: Optimal control by a fully dedicated person
Number of subjects: 12
Study: 11577835

Group type: EXPERIMENTAL
Intervention: 50 mg alteplase (15 mg as bolus, followed by an infusion of 35 mg over 60 min) plus tirofiban (0.4 mcg/kg/min for 30 min followed by an infusion of 0.1 mcg/kg/min for 3 days)
Number of subjects: 120
Study: 10021959

Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.5%
Number of subjects: 40

Group type: COMPARATOR
Intervention: Ropivacaine 0.5%
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study: 7931525

Group type: EXPERIMENTAL
Intervention: Tactile stimulation using a series of pulses applied to adjacent locations on the skin with varying spatiotemporal parameters.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Stimulation of only two points on the skin (start and stop locations).
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Total number of pulses in a sweep (eight or more).
Number of subjects: 0
Study: 3323074

Group type: EXPERIMENTAL
Intervention: Ceftazidime single preoperative 2 g intramuscular dose (group A)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Ceftazidime 3 perioperative 1 g intramuscular doses every 6 h (group B)
Number of subjects: 200
Study: 31361656

Group type: EXPERIMENTAL
Intervention: Ortho-k group 1 (target myopia reduction of 6.00 D)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Ortho-k group 2 (target myopia reduction of 4.00 D)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Control group (single-vision spectacles)
Number of subjects: 102
Study: 31290466

Group type: EXPERIMENTAL
Intervention: 4.3% dextrose in 0.18% saline (Group I)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Normal saline (Group II)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Ringer's lactate (Group III)
Number of subjects: 65
Study: 27336592

Group type: EXPERIMENTAL
Intervention: Healthy Kids-Houston program (3 sessions of 6 weeks, 2 sessions per week, 2 hours each session with 90 minutes of physical activity and 30 minutes of nutrition lessons)
Number of subjects: 877

Group type: COMPARATOR
Intervention: Control group (typical enrichment programs)
Number of subjects: 877
Study: 24834773

Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy (SLIT) with Pru p 3-enriched peach extract
Number of subjects: 0
Study: 22459675

Group type: EXPERIMENTAL
Intervention: Levodopa therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 20489032

Group type: EXPERIMENTAL
Intervention: High-CHO (H-CHO; 71 ± 3% CHO)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Low-CHO (L-CHO; 11 ± 1% CHO)
Number of subjects: 6
Study: 18457717

Group type: EXPERIMENTAL
Intervention: Carotid endarterectomy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Percutaneous treatment with distal protection
Number of subjects: 0
Study: 15670265

Group type: EXPERIMENTAL
Intervention: Education and pelvic exercise
Number of subjects: 23

Group type: COMPARATOR
Intervention: Education and biofeedback (BF) therapy
Number of subjects: 23
Study: 12200980

Group type: EXPERIMENTAL
Intervention: 6 mg/kg/24 h ferrous sulphate given orally for 3 months
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (12 healthy children; 6 boys, 6 girls; mean age 29 +/- 1.3 months)
Number of subjects: 18
Study: 10355008

Group type: EXPERIMENTAL
Intervention: Silver fluoride/stannous fluoride (AgF/SnF2)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Silver nitrate (AgNO3)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Silver diammine fluoride (SDF)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Chlorhexidine (CHX)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 85
Study: 8942398

Group type: EXPERIMENTAL
Intervention: Limb immobilization for 1 week
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Limb immobilization for 6 weeks
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Limb immobilization for 6 weeks (free leg)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Limb immobilization for 1 week (free leg)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Limb immobilization for 1 or 6 weeks
Number of subjects: 11
Study: 1775602

Group type: EXPERIMENTAL
Intervention: Nortriptyline (NTL)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 0
Study: 7147151

Group type: EXPERIMENTAL
Intervention: Erythromycin (1g daily for one week)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Tetracycline (1g daily for one week)
Number of subjects: 71
Study: 30378203

Group type: EXPERIMENTAL
Intervention: Mediterranean diet supplemented with two meals of 150 g of cooked fatty fish weekly
Number of subjects: 64

Group type: COMPARATOR
Intervention: Usual diet
Number of subjects: 64
Study: 27999848

Group type: EXPERIMENTAL
Intervention: Well-nourished patients
Number of subjects: 292

Group type: EXPERIMENTAL
Intervention: Nutritional status improvement
Number of subjects: 292

Group type: EXPERIMENTAL
Intervention: Trajectories of nutritional status
Number of subjects: 292

Group type: EXPERIMENTAL
Intervention: Cognitive function trajectories
Number of subjects: 292
Study: 25442659

Group type: EXPERIMENTAL
Intervention: Irrigation fluid with epinephrine
Number of subjects: 83

Group type: COMPARATOR
Intervention: Irrigation fluid without epinephrine
Number of subjects: 83
Study: 24992751

Group type: EXPERIMENTAL
Intervention: Electroacupuncture + massage + blocking therapy
Number of subjects: 86

Group type: COMPARATOR
Intervention: Blocking therapy alone
Number of subjects: 86
Study: 22587485

Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Laser therapy
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: LED therapy
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation and laser therapy
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation and LED therapy
Number of subjects: 50
Study: 17724210

Group type: EXPERIMENTAL
Intervention: Topical clonidine
Number of subjects: 12

Group type: COMPARATOR
Intervention: Topical brimonidine
Number of subjects: 12
Study: 15038091

Group type: EXPERIMENTAL
Intervention: LPZ(60 mg/d) alone
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: LPZ(60 mg/d) with CAM(400 mg/d) and AMPC(1,500 mg/d)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: LPZ(60 mg/d) with CAM(800 mg/d) and AMPC(1,500 mg/d)
Number of subjects: 3
Study: 11346854

Group type: EXPERIMENTAL
Intervention: PAPAW
Number of subjects: 11
Study: 9547961

Group type: EXPERIMENTAL
Intervention: Multi-sensory environment (MSE)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control condition (non-complex sensory environment)
Number of subjects: 27
Study: 7982254

Group type: EXPERIMENTAL
Intervention: Ampicillin/sulbactam (1 to 2 g ampicillin and 0.5 to 1 g sulbactam, administered intravenously once every 6 hours)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Cefuroxime (750 mg to 1.5 g, administered intravenously once every 8 hours)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Ampicillin/sulbactam
Number of subjects: 85

Group type: COMPARATOR
Intervention: Cefuroxime
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 85
Study: 2600246

Group type: EXPERIMENTAL
Intervention: 10-week group treatment program
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Graduated exposure procedures
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Subjective evaluation method and social comparison method
Number of subjects: 76